AMSTERDAM--(BUSINESS WIRE)--NorthSea Therapeutics B.V. (NST), a biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic ...
RAD101 targets fatty acid synthase, overexpressed in many solid tumors, to improve brain metastases imaging. Fast track designation by the FDA accelerates development for treatments addressing unmet ...
Shortness of breath, coughing, and respiratory infections. Childhood asthma, also known as asthmatic bronchitis, is one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results